Gene Screening in High-Throughput Right-Censored Lung Cancer Data

BACKGROUND: Advances in sequencing technologies have allowed collection of massive genome-wide information that substantially advances lung cancer diagnosis and prognosis. Identifying influential markers for clinical endpoints of interest has been an indispensable and critical component of the stati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Chenlu, Bandyopadhyay, Dipankar, Acunzo, Mario, Winn, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100230/
https://www.ncbi.nlm.nih.gov/pubmed/37066112
http://dx.doi.org/10.3390/onco2040017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100230/
https://www.ncbi.nlm.nih.gov/pubmed/37066112
http://dx.doi.org/10.3390/onco2040017

Ejemplares similares